Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations - Margetić, S; Ćelap, I; Delić Brkljačić, D (Biochem Med (Zagreb), 2020)